The Peripheral Stent Market is expected to register a CAGR of 6.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Product Type (Analgesics, Cold & Cough Medications, Digestive Health Products, Vitamins & Dietary Supplements, Topical Products, Others). The market is further segmented based on by Distribution Channel (Pharmacies & Drugstores, Supermarkets & Hypermarkets, Online Pharmacies, Convenience Stores). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the Report
The report Peripheral Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Peripheral Stent Market Segmentation
Product Type
- Self-Expanding Stents
- Balloon-Expandable Stents
- Covered Stents
- Drug-Eluting Stents
- Bioresorbable Stents
Indication
- Peripheral Artery Disease
- Coronary Artery Disease
- Renal Artery Disease
- Carotid Artery Disease
- Other Vascular Diseases
End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Peripheral Stent Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Peripheral Stent Market Growth Drivers
- Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases such as coronary artery disease and peripheral artery disease is a major driver for the peripheral stent market. As these conditions require stenting procedures for vascular support and blood flow restoration, the demand for peripheral stents continues to grow, especially in aging populations with higher risk factors.
- Technological Advancements in Stent Design: Advances in stent technology, including drug-eluting stents (DES), bioresorbable stents, and improved materials, are propelling the growth of the peripheral stent market. These innovations improve patient outcomes, reduce the risk of restenosis, and enhance the long-term effectiveness of stents, driving their adoption in clinical practice.
- Growing Geriatric Population: The global aging population is contributing to the growing peripheral stent market. Older individuals are more susceptible to peripheral artery disease and other vascular disorders, increasing the need for stent interventions. This demographic trend creates a steady demand for peripheral stents, particularly in developed countries with aging populations.
Peripheral Stent Market Future Trends
- Shift Towards Minimally Invasive Procedures: There is a growing trend toward minimally invasive procedures, including the use of peripheral stents, due to their ability to reduce recovery time and complications. Patients and healthcare providers prefer these procedures over traditional open surgeries, fueling the demand for advanced peripheral stents.
- Use of Drug-Eluting Stents (DES): Drug-eluting stents are increasingly popular in the treatment of peripheral artery disease due to their ability to release medication that prevents restenosis. This trend toward DES is driven by their higher efficacy in reducing the risk of stent blockage and improving long-term patient outcomes.
- Rise of Biodegradable Stents: Biodegradable or bioresorbable stents are gaining traction in the peripheral stent market. These stents provide temporary vascular support and gradually dissolve after achieving their therapeutic effect, reducing long-term complications and eliminating the need for further surgical interventions, a trend that is changing the landscape of stent technology.
Peripheral Stent Market Opportunities
- Expansion in Emerging Markets: Emerging markets, particularly in Asia-Pacific, Latin America, and Africa, offer significant growth opportunities for the peripheral stent market. Increased healthcare access, improving medical infrastructures, and rising cardiovascular disease rates in these regions drive the demand for peripheral stents, creating new revenue streams for global manufacturers.
- Innovation in Stent Materials: There is a growing opportunity for developing new stent materials, such as flexible alloys, polymers, and composites, that can enhance the performance and reduce complications associated with stents. Manufacturers can capitalize on this opportunity by investing in R&D to create superior stents with better biocompatibility, reduced thrombosis, and fewer adverse reactions.
- Integration with Advanced Imaging Technologies: The integration of peripheral stents with advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provides an opportunity for more accurate placement and monitoring of stents. This collaboration offers potential for improved patient outcomes and precision, driving the adoption of stents in clinical practice.
Peripheral Stent Market Regional Insights
The regional trends and factors influencing the Peripheral Stent Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Peripheral Stent Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for Peripheral Stent Market
Peripheral Stent Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2024 | US$ XX million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2025 - 2031) | 6.1% |
Historical Data | 2021-2023 |
Forecast period | 2025-2031 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Peripheral Stent Market Players Density: Understanding Its Impact on Business Dynamics
The Peripheral Stent Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Peripheral Stent Market are:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cordis (A Cardinal Health Company)
- Cook Medical
- Terumo Corporation
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Peripheral Stent Market top key players overview
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peripheral Stent Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Peripheral Stent Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- GNSS Chip Market
- Medical and Research Grade Collagen Market
- Dealer Management System Market
- Arterial Blood Gas Kits Market
- Electronic Toll Collection System Market
- Dry Eye Products Market
- Passport Reader Market
- Truck Refrigeration Market
- Trade Promotion Management Software Market
- Smart Mining Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors include the rising prevalence of cardiovascular diseases, advancements in stent technologies (e.g., drug-eluting and biodegradable stents), and an aging global population, all contributing to increased demand for peripheral stents.
Key trends include the growing use of drug-eluting stents (DES), the shift toward minimally invasive procedures, and the rise of biodegradable stents, all enhancing patient outcomes and stent performance.
Opportunities lie in expanding access to emerging markets, developing new stent materials, and integrating stents with advanced imaging technologies, which can improve precision and patient outcomes during stent placement.
North America and Europe are expected to dominate the market due to advanced healthcare systems, but emerging markets in Asia-Pacific, Latin America, and Africa offer significant growth opportunities due to improving medical access and rising cardiovascular disease rates.
Drug-eluting stents (DES), biodegradable stents, and self-expanding stents are in high demand due to their efficacy in preventing restenosis, improving long-term outcomes, and offering more biocompatible solutions for vascular conditions.
Challenges include the risk of restenosis (in-stent restenosis), high procedural costs, and the need for continuous innovation in stent materials to reduce complications like thrombosis and vascular injury, which may hinder market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cordis (A Cardinal Health Company)
- Cook Medical
- Terumo Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- Sorin Group (now LivaNova)
- Cardiovascular Systems, Inc